Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 2Phase NA 1Phase 4 1Phase 3 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Breast Neoplasms 1911Neoplasms 1531Prostatic Neoplasms 753Colorectal Neoplasms 714Lung Neoplasms 583Motor Activity 393Head and Neck Neoplasms 328Colonic Neoplasms 312Uterine Cervical Neoplasms 300Pain 248Pancreatic Neoplasms 246Anxiety Disorders 221Rectal Neoplasms 214Carcinoma, Hepatocellular 209Carcinoma, Non-Small-Cell Lung 206Fatigue 194Stomach Neoplasms 192Polycystic Ovary Syndrome 188Ovarian Neoplasms 186Precursor Cell Lymphoblastic Leukemia-Lymphoma 178Brain Neoplasms 169Depression 166Urinary Bladder Neoplasms 165Melanoma 163Neoplasm Metastasis 162Esophageal Neoplasms 140Multiple Myeloma 138Lymphoma 136Lymphoma, Follicular 128Obesity 127

Interventions

Resveratrol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Completed × Gastro-enteropancreatic neuroendocrine tumor × Clear all
NCT01476592 2019-11-18

A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors

University of Wisconsin, Madison

Phase NA Completed
7 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡